Osteomielitis hematogénica aguda en Pediatría: análisis de casos atendidos en hospital universitario by Puccini, Pedro Fiorini et al.
Rev Paul Pediatr 2012;30(3):353-8.
Original Article
Pediatric acute hematogenous osteomyelitis: analysis of patients 
assisted in a university hospital
Osteomielite hematogênica aguda em Pediatria: análise de casos atendidos em hospital universitário
Osteomielitis hematogénica aguda en Pediatría: análisis de casos atendidos en hospital universitario
Pedro Fiorini Puccini1, Maria Aparecida G. Ferrarini2, Antônio Vladir Iazzetti3
Instituição: Escola Paulista de Medicina da Universidade Federal de São 
Paulo (Unifesp), São Paulo, SP, Brasil
1Graduação em Medicina pela Escola Paulista de Medicina da Unifesp, 
São Paulo, SP, Brasil
2Mestre em Pediatria pela Escola Paulista de Medicina da Unifesp, São 
Paulo, SP, Brasil
3Doutor em Pediatria; Professor Adjunto na Escola Paulista de Medicina da 
Unifesp, São Paulo, SP, Brasil
ABSTRACT 
Objective: To describe occurrence, evolution, and out-
come of acute hematogenous osteomyelitis in children and 
adolescents. 
Methods: A descriptive study of 21 cases with patients 
aged zero to 14 years-old, diagnosed with acute hematog-
enous osteomyelitis assisted at the Pediatric Infectious 
Disease Follow-Up Clinic of Escola Paulista de Medicina, 
between 2005 and 2009. The medical records were reviewed. 
Descriptive analysis and Spearman’s rank correlation were 
performed, with a 95% confidence interval. 
Results: The incidence in males was higher than in 
females, and children over five years of age were the most 
affected ones. Fever and pain were the main symptoms, 
and the long bones were the most often affected. The most 
commonly recovered pathogen was Staphylococcus aureus. 
The time interval between the onset of symptoms and the 
diagnosis was 9.7 days, the length of hospital stay was 
24.7 days, and the duration of treatment was 71.7 days. 
Complete resolution occurred in 71.4% of the cases and 
complications appeared in 28.6% of them, being chronic 
osteomyelitis the main one. 
Conclusions: Data regarding gender, age, etiology, and 
evolution were in accordance with literature reports. The 
duration of the treatment was ten weeks, which is longer 
than usual reports. There were no significant correlations 
between duration of symptoms before the diagnosis, dura-
tion of hospital stay, and duration of treatment, considering 
the small sample size.
Key-words: osteomyelitis; children; /etiology; clinical 
evolution; treatment.
RESUMO
Objetivo: Descrever a ocorrência, a evolução e o desfecho 
de pacientes com osteomielite hematogênica aguda na faixa 
etária pediátrica. 
Métodos: Estudo descritivo de 21 casos de pacientes de 
zero a 14 anos com diagnóstico de osteomielite hematogênica 
aguda, em acompanhamento no Ambulatório de Infectologia 
Pediátrica da Escola Paulista de Medicina entre 2005 e 2009. 
A coleta de dados ocorreu pelo levantamento de prontuários. 
Realizaram-se a análise descritiva e o teste de correlação de 
Spearman, com intervalo de confiança de 95%. 
Resultados: Foi identificada maior incidência no sexo 
masculino e em crianças maiores de cinco anos. Febre e dor 
foram os sintomas mais frequentes. Os ossos longos foram os 
mais acometidos. O principal agente etiológico identificado 
foi o Staphylococcus aureus. Em média, o tempo de sintoma-
tologia até o diagnóstico foi de 9,7 dias, o de internação, 
24,7 dias, e o total de antibioticoterapia foi de 71,7 dias. A 
resolução completa do quadro ocorreu em 71,4% dos casos, 
com permanência de sequelas em 28,6% deles, sendo a evo-
lução para osteomielite crônica a principal delas. 
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Conclusões: As características dos pacientes e da doença 
referentes a sexo,  idade,  etiologia e  evolução mostram-se 
concordantes com o descrito na literatura. O tempo de tra-
tamento foi de aproximadamente dez semanas, valor acima 
do habitualmente encontrado nos diferentes estudos. Não 
foram encontradas correlações significantes entre o tempo 
de sintomatologia até o diagnóstico, o tempo de internação 
e o tempo total de antibioticoterapia, havendo a limitação 
do tamanho da amostra.
Palavras-chave: osteomielite; crianças; /etiologia; evo-
lução clínica; tratamento. 
RESUMEN
Objetivo: Describir la ocurrencia, la evolución y el des-
enlace de pacientes con osteomielitis hematogénica aguda 
en la franja de edad pediátrica. 
Métodos: Estudio descriptivo de 21 casos de pacientes de 
cero a 14 años con diagnóstico de osteomielitis hematogénica 
aguda, en seguimiento en el Ambulatorio de Infectología 
Pediátrica de la Escola Paulista de Medicina, entre 2005 y 
2009. La recolección de datos ocurrió por el inventario de 
prontuarios. Se realizaron análisis descriptivo y la prueba de 
correlación de Spearman, con intervalo de confianza de 95%. 
Resultados: Se identificó mayor incidencia en el sexo mas-
culino y en niños con más de cinco años. Fiebre y dolor fueron 
los síntomas más frecuentes, y los huesos largos fueron los más 
atingidos. El principal agente etiológico identificado fue el 
Staphylococcus aureus. En promedio, el tiempo de sintoma-
tología hasta el diagnóstico fue de 9,7 días; el de internación, 
24,7 días y el total de antibioticoterapia fue de 71,7 días. La 
resolución completa del cuadro ocurrió en 71,4% de los casos, 
habiendo permanencia de secuelas en 28,6% de ellos, siendo 
la evolución para osteomielitis crónica la principal de ellas. 
Conclusiones: Las características de los pacientes y de la 
enfermedad referentes a sexo, edad, etiología y evolución se 
mostraron concordantes con lo descrito por la literatura. El 
tiempo de tratamiento fue de aproximadamente diez sema-
nas, valor superior al habitualmente encontrado en los dis-
tintos estudios. No se encontraron correlaciones significantes 
entre el tiempo de sintomatología hasta el diagnóstico, el 
tiempo de internación y el tiempo total de antibioticoterapia, 
habiendo la limitación del tamaño de la muestra.
Palabras clave: osteomielitis; niños; etiología; evolución 
clínica; tratamiento. 
Introduction
Hematogenous osteomyelitis is an invasive bacterial dis-
ease currently classified as an important cause of morbidity 
in childhood. Its annual incidence, unchanged in the last 
decades, ranges from 1:5,000 to 1:10,000 children and is 
two times higher among boys(1,2). 
Signs and symptoms of osteomyelitis, although well 
known, are not specific and vary according to age due to the 
dissemination of local infection, which may reach even the 
adjacent joint in newborns. Its diagnosis depends on clinical 
suspicions primarily and, when made at an appropriate time 
and followed by the initiation of adequate treatment, leads 
to good outcomes for most patients, with complication rates 
of about 5% and mortality close to zero(3,4). 
Surgery is not always necessary in cases of hematogenous 
osteomyelitis. Treatment is basically defined as general 
patient care, such as hydration, analgesia and treatment 
of anemia, when necessary, as well as the administration 
of antibiotics to fight the probable pathogen and to avoid 
progressive tissue necrosis and complications. Such compli-
cations may include the progression to chronic osteomyelitis, 
pathological fracture, joint instability and changes in the 
epiphyseal plate(5). 
In all age groups, empirical treatment with antibiotics 
is initiated according to the most probable pathogen and 
should include Staphylococcus aureus. For newborns, addi-
tional coverage should be provided against Gram-negative 
bacteria(6). The duration of IV antibiotic administration 
should be defined by the fever curve and clinical progres-
sion, and it is usually about two weeks. In cases there are 
signs of uncontrolled infection one week after the initiation 
of adequate antibiotics, the chance of complications should 
be evaluated(6,7). Total antibiotic treatment time is usually 
long and ranges from four to eight weeks for acute osteo-
myelitis in different studies(1-4). Its discontinuation should 
be decided based on the improvement of the lesion and the 
general condition of the patient, as well as on inflammation 
markers, particularly erythrocyte sedimentation rate (ESR). 
Studies in the literature suggest that good progression is 
primarily associated with use of adequate antibiotics, absence 
of comorbidities and early diagnosis(5). 
Recent studies compared different diagnostic methods, fo-
cusing on whether an early diagnosis may be established(8-12). 
Moreover, different patient groups have been studied to 
define the disease characteristics, its progression and changes 
along time, particularly in determinant factors of better or 
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worse prognoses, such as etiology and the patterns of patho-
gen resistance to antimicrobial drugs(13-17).
Therefore, this study discusses the characteristics of a 
group of patients to provide a better understanding of clini-
cal presentations, treatment strategies and disease progres-
sion. For that purpose, it describes the occurrence, progres-
sion and outcome of acute hematogenous osteomyelitis in 
patients seen in the Pediatric Infectious Disease Outpatient 
Clinic of Escola Paulista de Medicina, Universidade Federal 
de São Paulo (Unifesp), São Paulo, Brazil.
Methods
This descriptive case series included patients aged zero 
to 14 years with a diagnosis of hematogenous osteomyelitis 
followed up in the Pediatric Infectious Disease Outpatient 
Service of Escola Paulista de Medicina, Unifesp, from 
February 2005 to October 2009. 
The variables under study were those that describe the 
disease, such as sex, age, site affected, isolated pathogen and 
type of treatment, as well as time to diagnosis, hospital stay 
and duration of antibiotic treatment.
Medical charts were reviewed after identifying the 
patients with osteomyelitis according to outpatient visit 
records. Sixty-six cases of osteomyelitis were found, and 
their medical charts in the Medical and Statistical Filing 
Service of Hospital São Paulo were reviewed. Sixty charts 
were retrieved and analyzed, and 21 were cases of acute he-
matogenous osteomyelitis. Of the cases excluded, 17 were 
not hematogenous, 12 were chronic osteomyelitis, seven had 
an unspecific diagnosis. 
Excel 2000 for Windows 7 Home Premium was used 
to build the database and analyze data descriptively. The 
Statistical Package for the Social Sciences (SPSS) 10.0 was 
used for statistical analysis (Spearman rank correlation) with 
95% confidence intervals (α=0.05).
This study was approved by the Ethics in Research 
Committee of Unifesp and Hospital São Paulo.
Results
The 21 cases of acute hematogenous osteomyelitis were 
analyzed according to two age groups: 0 to less than 5, and 
5 to 14 years. The first group had 38.1% of the cases, and 
the second, 61.9%. In both groups, there were more boys, 
at a rate of 76.2% of all patients in the two age groups.
The analysis of trauma in clinical history and use of anti-
biotics before the diagnosis of osteomyelitis were analyzed 
revealed that trauma was denied in 76.2% of the cases, but 
prior use of antibiotics was recorded for 47.6%. 
The most frequent symptoms were fever and pain, found 
in over 70% of the cases. The analysis of site of infection re-
vealed that osteomyelitis of the femur was the most frequent 
and accounted for one third of the cases (Table 1). 
The analysis of underlying or previous pathologies re-
vealed that three patients had a history of septic arthritis and 
Table 2 - Isolated pathogen* in culture and susceptibility tests 
of acute hematogenous osteomyelitis cases seen in the Pedia-
tric Infectious Disease Outpatient Clinic of Escola Paulista de 
Medicina from 2005 to 2009
Pathogen n %
Oxacillin-susceptible Staphylococcus aureus 7 33.3
Oxacillin-resistant Staphylococcus aureus 2 9.5
Oxacillin-resistant coagulase-negative 
Staphylococcus 1 4.8
Streptococcus agalactiae 1 4.8
Streptococcus pyogenes 1 4.8
Acinetobacter baumannii susceptible to 
several antimicrobials 1 4.8
Enterobacter spp 1 4.8
Not identified 7 33.3
Total 21 100.0
*Isolated in blood, bone fragment or secretion culture.
Table 1 - Characteristics of acute hematogenous osteomyelitis 
cases seen in the Pediatric Infectious Disease Outpatient Clinic 
of Escola Paulista de Medicina from 2005 to 2009
Characteristic Yes % No % Total
Symptoms – clinical conditions
Fever 15 71.4 6 28.6 21
Pain 15 71.4 6 28.6 21
Edema 11 52.4 10 47.6 21
Functional disability 11 52.4 10 47.6 21
Hyperemia 5 23.8 16 76.2 21
High temperature 5 23.8 16 76.2 21
Affected site
Femur 7 33.3 14 66.7 21
Tibia 6 28.6 15 71.4 21
Humerus 3 14.3 18 85.7 21
Iliac 2 9.5 19 90.5 21
Fibula 1 4.8 20 95.2 21
Foot 1 4.8 20 95.2 21
Finger 1 4.8 20 95.2 21
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two had hemoglobinopathies. The following comorbidities 
were found in one case each: juvenile idiopathic arthritis, 
systemic hypertension, cellulitis and genetic syndrome.
Pathogens were identified in 14 of the 21 cases (66.7%) 
in blood culture (six cases), bone fragment culture (four 
cases), or secretion culture (eight cases). Table 2 shows that 
Staphylococcus was responsible for 71.4% of the cases for which 
the pathogen was isolated. Infection by coagulase-negative 
Staphylococcus was recorded for one case in which the same 
pathogen was isolated in bone fragment and secretion cul-
tures. Although not usual, that patient was at school age 
and had no immunodeficiency.
The initial empirical antibiotic regimens were based on 
the most frequent pathogens of osteomyelitis. In eight cases 
(38.1%), initial treatment used oxacillin and ceftriaxone; 
in six (28.6%), oxacillin; and in two (9.5%), cephalo-
thin. Vancomycin was introduced as the initial empirical 
treatment in two cases (9.5%) with a history of previous 
hospitalizations due to septic arthritis. The associations 
of oxacillin and amikacin, cephalothin and amikacin, and 
ampicillin and gentamicin were administered in one case 
each (4.8%) for newborns.
In addition to treatment with antibiotics, 14 patients 
(66.7%) also underwent at least one surgical debridement 
procedure. Treatment in hyperbaric chamber, however, was 
not used in any case in this study.
Treatment had to be changed during the progression of 
the cases due to different reasons. Hospital discharge, when 
IV antibiotics have to be replaced with oral equivalents, 
was the main reason and accounted for 35% of the changes. 
The results of antimicrobial susceptibility tests and the fact 
that oxacillin was not available in the hospital accounted for 
20% of the changes each. Clinical factors were responsible 
for 15% of the changes, and laboratory findings, for 10%.
During outpatient follow-up, six patients (28.6%) had 
sequelae, such as progression to chronic osteomyelitis, seen 
in three cases. Deformities and limitation of movement range 
were found in one case each and were associated in another 
case. The two patients that had movement range limitations 
had osteomyelitis in the neonatal period. 
ESR was the main test for inflammation during the clini-
cal and laboratory follow-up of these cases of osteomyelitis. 
Graph 1 compares the dispersion of ESR values at admission, 
discharge and discontinuation of antibiotic treatment. ESR 
values at admission varied greatly and lied within the normal 
range in some cases. In contrast, at the time of antibiotic 
discontinuation, they were clearly more homogeneous.
Time to diagnosis, duration of hospital stay and duration 
of antibiotic treatment are shown in Table 3. Mean values 
for each time were 9.7, 24.7 and 71.7 days.
The correlation between progression time for the cases 
under study was analyzed to investigate whether a shorter 
time to diagnosis would result in shorter of hospitalization 
and antibiotic treatment duration. However, there were no 
statistically significant correlations between these variables 
(Spearman rank correlation, p>0.05). 
Discussion
In this descriptive study of 21 cases of acute hematogenous 
osteomyelitis in a pediatric population, the male-to-female 
ratio was 3.2:1. Although Riise et al(16) did not find any 
difference between sexes in the incidence of osteomyelitis, 
most studies(1,13-15) effectively demonstrated a predominance 
of male sex. Zaoutis et al(17), for example, found that boys 
were affected in 62% of the cases.
The analysis of distribution according to age group in 
our study showed that the incidence in children younger 
than five years and in those five years or older was 38.1% 
and 61.9%. This result is in agreement with that reported 
by Zaoutis et al(17), who studied children aged 2 months to 
17 years and found an incidence of 42% and 58% for the 
same age groups.
Graph 1 - Comparison of ESR values at three time points in 
the progression of acute hematogenous osteomyelitis cases
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In agreement with other studies in the literature, the most 
frequently affected sites were the long bones, with the femur 
in 34% of the cases, the tibia in 28% and the humerus in 
14%. According to Weichert et al(1), the femur is affected in 
36% of the cases, the tibia in 33%, and the humerus in 10%. 
In our study, pathogens were detected in 67% of the 
21 cases, most often in secretion cultures. Arnold et al(14) 
identified pathogens in 48% of their cases of osteomyelitis, 
and Goergens et al(18), in 45%, whereas Moumile et al(13) 
collected data for 186 cases of bone infection and identified 
pathogens in 19%.
Staphylococcus aureus was isolated in 64% of the cases for 
which the pathogen was identified. Streptococcus pyogenes 
and Streptococcus agalactiae were isolated in one case each 
(0.7%). Moumile et al(13) found Staphylococcus aureus in 60% 
of the cases with isolates, whereas Streptococcus pyogenes and 
Streptococcus agalactiae were responsible for 0.8% of the cases 
each. Streptococcus pneumoniae was isolated in 13% of the cases 
for which the pathogen was known in the study conducted 
by Moumile et al(13), but was not found in our study.
Of the nine bacteria of the Staphylococcus aureus iso-
lated in our study, two (28%) were resistant to oxacillin. 
Arnold et al(14) identified Staphylococcus aureus in 34 cases 
of osteomyelitis, 23 (67%) of which were caused by 
oxacillin-resistant pathogens.
In the service where our study was conducted, there are 
no routine methods to identify Kingella kingae, a pathogen 
that has been shown to play an important role in bone and 
joint infections in children, particularly those younger 
than 2 years(14,19).
The median ESR value at admission was 76.0mm/h 
(Q1=40.0 and Q3=97.5). For the same time point, Riise et 
al(16) found lower and more homogeneous values, at 41mm/h 
(Q1=27 and Q3=52). The same authors also found that 
median duration of symptoms until admission was 8 days, 
the same value found in our study.
Mean duration of antibiotic treatment in our study was 
about 10 weeks (71.7 days). As mentioned before, treatment 
duration is long and variable in different studies. Weichert 
et al(1) reviewed publications about the duration of acute 
osteomyelitis treatment in children and found that mean 
antibiotic treatment lasted up to 12 weeks according to 
Blockey and Watson(20); from six to nine weeks in the study 
by Kolyvas et al(21); six weeks, according to Kulhanjian et 
al(22); two weeks according to Jacobs et al(23); and in the study 
by Peltola et al(24), three weeks.
Although an early diagnosis is extremely important in he-
matogenous osteomyelitis, there are no data in the literature 
to estimate statistically significant values for time of diagno-
sis after first symptom and case progression. Because of the 
size of our study sample, no correlation was established be-
tween time to diagnosis and duration of hospitalization and 
antibiotic treatment (Spearman rank correlation, p>0.05). 
This study showed that acute hematogenous osteomyeli-
tis is an important infection among children, particularly 
those in pre-school or school. The disease should be classi-
fied as a severe bacterial infection that requires hospitaliza-
tion and antibiotic treatment for a long time, and whose 
progression results in permanent sequelae for a substantial 
number of patients. 
→
Table 3 - Time in days between events in the progression o acute hematogenous osteomyelitis cases seen in the Pediatric Infec-
tious Disease Outpatient Clinic of Escola Paulista de Medicina from 2005 to 2009
Ethnicity
Difference between time points
n
Time in days
Initial time point  Final time point Mean Median Q25 Q75
Time to diagnosis Onset of clinical signs and symptoms
Initiation of empirical 
antibiotic treatment for 
osteomyelitis
21 9.7 8.0 5.5 14.0
Hospitalization time
Initiation of empirical 
antibiotic treatment for 
osteomyelitis
Hospital discharge 21 24.7 18.0 13.0 41.5
Total antibiotic 
treatment duration
Initiation of empirical 
antibiotic treatment for 
osteomyelitis
Discontinuation of 
antibiotic treatment 19 71.7 64.0 54.0 81.0
Q: quartile.
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